State Ledger
Company profile

Rallybio Corp CIK 1739410

Ticker
RLYB (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
New Haven, CT 06510
Fiscal year end
2025 (FY)
Market Data
Close
$17.10
Change
+$0.10
Change %
0.56%
Volume
141

RLYB · trading date Oct 9, 2026 · previous close $17.01 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$858.0K
Net income
-$8.98M
Total assets
$62.26M
Total liabilities
$4.31M
Stockholders' equity
$57.96M
Cash & equivalents
$31.37M
Operating income
-$33.06M
Operating cash flow
-$29.81M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-16. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-3,853.6%
Net margin
-1,046.4%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
6.9%
Equity / assets
93.1%
CapEx / revenue
—
Operating cash flow / net income
3.32×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $858.0K -$8.98M $62.26M $4.31M $57.96M
2024 $636.0K -$57.78M $68.11M $6.45M $61.65M
2023 — -$74.56M $115.62M $9.44M $106.18M
2022 — -$66.65M $180.44M $11.12M $169.32M
2021 — -$47.01M $182.19M $6.58M $175.60M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-16

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New Haven, CT 06510
234 CHURCH STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:23 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Connecticut — Public Companies